Effective pharmacotherapy of osteoporosis in perimenopause

М. Khabibulina, М. Shamilov, D. Elistratov
In: Vrach · 2024 · pp. 38–40 · doi:10.29296/25877305-2024-11-07 · W4404521952
article OA: closed CC0
View on OpenAlex View at publisher

Abstract

Osteoporosis (OP) is a disease characterized by a decrease in bone mineral density (BMD) and a high risk of fractures. In perimenopausal women with a disturbed hormonal background, the risk of developing this pathology increases significantly. Special diagnostic methods and therapy that take into account the etiopathogenesis of the disease can reduce the disability rates associated with OP among patients of this group. The article provides data on the results of examination and treatment of 57 perimenopausal women with OP and reveals the potential of diagnostics that allows evaluating the effectiveness of therapy. The drug "Osteomed Forte" has shown effectiveness in reducing and closing cavities in the trabecular bone sections in patients with verified OP and androgen deficiency, and improving hormonal status in perimenopause allowed to suspend the development of OP and even achieve its partial regression.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

References (10)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-07-11T06:40:09.570059+00:00
License: CC0 · commercial use OK